001     861126
005     20210130000722.0
024 7 _ |a 10.1242/jcs.199612
|2 doi
024 7 _ |a 0021-9533
|2 ISSN
024 7 _ |a 0370-2952
|2 ISSN
024 7 _ |a 1477-9137
|2 ISSN
024 7 _ |a pmid:30659114
|2 pmid
024 7 _ |a WOS:000461414300006
|2 WOS
024 7 _ |a 2128/22881
|2 Handle
037 _ _ |a FZJ-2019-01683
082 _ _ |a 570
100 1 _ |a Kant, Sebastian
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Desmoglein 2 mutation provokes skeletal muscle actin expression and accumulation at intercalated discs in murine hearts
260 _ _ |a Cambridge
|c 2019
|b Company of Biologists Limited
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1551162387_12690
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Arrhythmogenic cardiomyopathy (AC) is an incurable progressive disease that is linked to mutations in genes coding for components of desmosomal adhesions that are localized to the intercalated disc region, which electromechanically couples adjacent cardiomyocytes. To date, the underlying molecular dysfunctions are not well characterized. In two murine AC models, we find an upregulation of the skeletal muscle actin gene (Acta1), which is known to be a compensatory reaction to compromised heart function. Expression of this gene is elevated prior to visible morphological alterations and clinical symptoms, and persists throughout pathogenesis with an additional major rise during the chronic disease stage. We provide evidence that the increased Acta1 transcription is initiated through nuclear activation of the serum response transcription factor (SRF) by its transcriptional co-activator megakaryoblastic leukemia 1 protein (MKL1, also known as MRTFA). Our data further suggest that perturbed desmosomal adhesion causes Acta1 overexpression during the early stages of the disease, which is amplified by transforming growth factor β (TGFβ) release from fibrotic lesions and surrounding cardiomyocytes during later disease stages. These observations highlight a hitherto unknown molecular AC pathomechanism.
536 _ _ |a 552 - Engineering Cell Function (POF3-552)
|0 G:(DE-HGF)POF3-552
|c POF3-552
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Freytag, Benjamin
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Herzog, Antonia
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Reich, Anna
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Merkel, Rudolf
|0 P:(DE-Juel1)128833
|b 4
|u fzj
700 1 _ |a Hoffmann, Bernd
|0 P:(DE-Juel1)128817
|b 5
|u fzj
700 1 _ |a Krusche, Claudia A.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Leube, Rudolf E.
|0 0000-0002-5519-7379
|b 7
773 _ _ |a 10.1242/jcs.199612
|g Vol. 132, no. 5, p. jcs199612 -
|0 PERI:(DE-600)1483099-1
|n 5
|p jcs199612 -
|t Journal of cell science
|v 132
|y 2019
|x 1477-9137
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/861126/files/jcs199612.full-1.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/861126/files/jcs199612.full-1.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:861126
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)128833
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)128817
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-552
|2 G:(DE-HGF)POF3-500
|v Engineering Cell Function
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J CELL SCI : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-7-20110106
|k ICS-7
|l Biomechanik
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-7-20110106
981 _ _ |a I:(DE-Juel1)IBI-2-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21